Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
containing: carbidopa, levodopa, entacapone · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | - |
| 2 | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg) | DRUG | - |
Inclusion Criteria: * Aged 30 to 80 years, inclusive, at time of Parkinson's disease diagnosis * Idiopathic Parkinson's disease with at least 2 cardinal signs of disease: resting tremor, bradykinesia or rigidity * Parkinson's disease impairment warranting treatment with a levodopa formulation accor...